Discussions with Younger TAVR Patients Will Encompass Limited Evidence and ‘Clear Preference’ for Less Invasive Treatment: State-of-the-Art Review
Discussions with patients that balance unanswered questions over transcatheter aortic valve replacement (TAVR) in low-risk populations – particularly those of younger age – with patients’ “clear preference” for less invasive treatment will become more common, cardiology experts predict.